The store will not work correctly when cookies are disabled.
4-(Pyridin-4-yldiazenyl)-1H-pyrazole-3,5-diamine
ID: ALA3402056
Chembl Id: CHEMBL3402056
PubChem CID: 135744101
Max Phase: Preclinical
Molecular Formula: C8H9N7
Molecular Weight: 203.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1n[nH]c(N)c1/N=N/c1ccncc1
Standard InChI: InChI=1S/C8H9N7/c9-7-6(8(10)15-14-7)13-12-5-1-3-11-4-2-5/h1-4H,(H5,9,10,14,15)/b13-12+
Standard InChI Key: RZLCSJZALMLKCU-OUKQBFOZSA-N
Associated Targets(Human)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Calculated Properties
| Molecular Weight: 203.21 | Molecular Weight (Monoisotopic): 203.0919 | AlogP: 1.38 | #Rotatable Bonds: 2 |
| Polar Surface Area: 118.33 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.78 | CX Basic pKa: 4.67 | CX LogP: 0.49 | CX LogD: 0.49 |
| Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.64 | Np Likeness Score: -0.84 |
References
| 1. Jorda R, Schütznerová E, Cankař P, Brychtová V, Navrátilová J, Kryštof V.. (2015) Novel arylazopyrazole inhibitors of cyclin-dependent kinases., 23 (9): [PMID:25835357] [10.1016/j.bmc.2015.03.025] |
